Cingulate to Host CNS Key Opinion Leader Panel in New York
Expert Analysis of Cingulate, its Phase 3 ADHD Adult Data, Anxiety, and PTR™ Drug Delivery Platform Innovations...
Source: globenewswire.com
Tx 1301 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tx 1301. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tx 1301 Today - Breaking & Trending Today
Cingulate Inc. Reports First Quarter 2023 Financial Results
Additional $3 Million of Financing Proprietary PTR™ Manufacturing Processes Successfully Transferred to Societal CDMO Joint Commercialization Agreement for...
Source: globenewswire.com
Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301,
Trial Results Expected 1H 2023 Company to Host Investor and Business Development Meetings Adjacent to Upcoming J.P. Morgan Healthcare Conference in...
Source: globenewswire.com